You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Double Cord Blood Transplantation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Platelet Recovery After Umbilical Cord Blood Transplantation Trial in Hefei (Avatrombopag)

Recruiting
  • Platelet Recovery After Umbilical Cord Blood Transplantation
  • Hefei, Anhui, China
    The First Affiliated Hospital of University of Science and Techn
Apr 19, 2023

Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)

Recruiting
  • Hematopoietic Stem Cell Transplantation
  • Malignant Hematological Diseases
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Jul 3, 2023

Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

Recruiting
  • Hematopoietic Malignancy
  • +2 more
  • Umbilical Cord Blood Transplantation
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow university
Nov 6, 2023

Stem Cell Transplantation Trial in Durham (Thymic Transplantation for Recipients of UCB transplant)

Terminated
  • Stem Cell Transplantation
  • Thymic Transplantation for Recipients of UCB transplant
  • Durham, North Carolina
    Duke University Health System
Mar 21, 2022

Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

Not yet recruiting
  • Acute Leukemia of Ambiguous Lineage
  • +8 more
  • Biospecimen Collection
  • +12 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 22, 2023

Acute Leukemia, Immune Deficiency Disorder, Congenital Hematological Disorder Trial in Rochester (radiation, drug, procedure)

Recruiting
  • Acute Leukemia
  • +9 more
  • Total Body Irradiation 1200 cGy
  • +7 more
  • Rochester, New York
    Wilmot Cancer Institute
Jun 20, 2022

Leukemia, Myelodysplastic Syndrome, Lymphoma Trial in New York (CliniMACS Fractionation system (Arm A), CliniMACS Fractionation

Completed
Has Results
  • Leukemia
  • +2 more
  • CliniMACS Fractionation system (Arm A)
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 12, 2022

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Aurora, Seattle (drug, procedure,

Active, not recruiting
  • Acute Biphenotypic Leukemia
  • +18 more
  • Aurora, Colorado
  • +2 more
Dec 28, 2022

Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Seattle

Recruiting
  • Acute Biphenotypic Leukemia
  • +5 more
  • Dilanubicel
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 11, 2022

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +5 more
Nov 1, 2022

Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States

Recruiting
  • Acute Myelogenous Leukemia (AML)
  • +5 more
  • Conditioning Chemotherapy
  • Cord blood graft
  • Basking Ridge, New Jersey
  • +6 more
May 22, 2023

Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)

Recruiting
  • Leukemia
  • +2 more
  • applying of FLU+CY post-HSCT
  • Guangzhou, Guangdong, China
    Nanfang Hospital
Nov 23, 2023

Cord Blood Transplantation With CCR5?32 Donor Cells on HIV

Active, not recruiting
  • HIV Infection
    • New York, New York
      Weill Cornell Uptown Clinical Research Site (7803)
    Feb 3, 2022

    AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)

    Recruiting
    • AML
    • +8 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    May 13, 2022

    Acute Leukemia Trial in Tianjin (Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation,

    Recruiting
    • Acute Leukemia
    • Combined haploidentical and umbilical cord blood allogeneic stem cell transplantation
    • haploidentical hematopoietic stem cell transplantation
    • Tianjin, Tianjin, China
      Institute of Hematology & Blood Diseases Hospital, Chinese Acade
    Aug 9, 2022

    Leukemia, Myelodysplastic Syndrome, Non-Hodgkins Lymphoma Trial in New York (fludarabine, cyclophosphamide, thiotepa, radiation

    Completed
    Has Results
    • Leukemia
    • +4 more
    • fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 10, 2022

    Poor Graft Function Trial (decitabine, umbilical cord blood, Granulocyte-colony stimulating factor)

    Not yet recruiting
    • Poor Graft Function
    • (no location specified)
    Dec 29, 2022

    Adrenoleukodystrophy, Batten Disease, Mucopolysaccharidosis II Trial in Durham (DUOC-01)

    Recruiting
    • Adrenoleukodystrophy
    • +11 more
    • DUOC-01
    • Durham, North Carolina
      Duke University Medical Center
    Oct 24, 2022

    UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Wuhan (Basic

    Recruiting
    • UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
    • Basic chemotherapy + UCB transplantation
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Oct 9, 2022

    Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in Aurora,

    Completed
    • Acute Biphenotypic Leukemia
    • +6 more
    • Aurora, Colorado
    • +2 more
    Jan 12, 2022

    High Risk Hematological Malignancy, Cord Blood Transplant Trial in Seattle (ECT-001-CB (UM171-Expanded Cord Blood Transplant))

    Recruiting
    • High Risk Hematological Malignancy
    • Cord Blood Transplant
    • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
    • Seattle, Washington
      Fred Hutchinson / University of Washington Cancer Consortium
    Jan 12, 2022

    Leukemia Trial in Badalona, Hospitalet de Llobregat, Barcelona (DLI of the 20 fraction of the UCBT)

    Completed
    • Leukemia
    • DLI of the 20 fraction of the UCBT
    • Badalona, Barcelona, Spain
    • +4 more
    Dec 3, 2021

    Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Recombinant Interleukin-7
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 26, 2023

    Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)

    Active, not recruiting
    • Primary Myelofibrosis
    • Secondary Myelofibrosis
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +11 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 10, 2023

    Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission Trial in United

    Completed
    Has Results
    • Acute Biphenotypic Leukemia
    • +4 more
    • Duarte, California
    • +7 more
    Jun 13, 2021